LABOGENE A/S: Financial statements 2020
CVR: 39969238
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
LABOGENE A/S (CVR 39969238) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 19,073,793 and a net result of DKK 4,659,695. Equity in the 2020 report amounted to DKK 9,401,869. The solvency ratio was 42.9%. The company had 26 employees in the financial year.
- Gross Profit
- DKK 19,073,793
- Profit/Loss
- DKK 4,659,695
- Equity
- DKK 9,401,869
- Total Assets
- DKK 21,933,823
- Employees
- 26
Official annual report
How creditworthy is LABOGENE A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 2, 2020, Tove Madsen has stepped down as director of LABOGENE A/S.
LABOGENE A/S has published its interim report for the period October 23, 2018 – December 31, 2019.
About LABOGENE A/S
LABOGENE A/S is a Danish company of the type Aktieselskab based in Allerød, founded in 2018. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Mikal Skat Nørrevig. The board consists of To CHEUNG (chair), Ching Cheung, Kar Chi Paul CHEN and Kar Yee CHEN. The company is owned by GENE COMPANY LIMITED. The company has 44 employees (2018). In 2025, the company reported a gross profit of DKK 15,195,981 and a net result of DKK 1,331,395 compared with DKK 1,306,291 the year before. Equity in the 2025 report amounted to DKK 18,517,822.